國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907251      Online Users : 906
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Papers [0/1]
    Patents [0/82]
    Periodical Articles [110/110]
    Conference Papers/Meeting Abstract [10/19]

    Community Statistics


    Item counts issued in 3 years:1(0.47%)
    Items With Fulltext:120(56.60%)

    Download counts of the item
    Download times greater than 0:120(100.00%)
    Download times greater than 100:120(100.00%)
    Total Bitstream Download Counts:99152(1.85%)

    Last Update: 2024-12-01 09:15

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-50 of 212. (5 Page(s) Totally)
    1 2 3 4 5 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2022-11 Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone Bioorganic Chemistry. 2022 Nov;128:Article number 105905.
    2021-08-01 DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity Life Sciences. 2021 Aug 1;278:Article number 119574.
    2021-01 BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy Translational Oncology. 2021 Jan;14(1):Article number 100897.
    2019-07 BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 227.
    2019-04-01 A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus European Journal of Medicinal Chemistry. 2019 Apr 1;167:245-268.
    2019-04-01 The in vivo antinociceptive and mu-opioid receptor activating effects of the combination of N-phenyl-2′,4′-dimethyl-4,5′-bi-1,3-thiazol-2-amines and naloxone European Journal of Medicinal Chemistry. 2019 Apr 1;167:312-323.
    2019-03 Synthesis and biological evaluation of N-glucosyl indole derivatives as sodium-dependent glucose co-transporter 2 inhibitors Bioorganic Chemistry. 2019 Mar;83:520-525.
    2018-04 4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy Bioorganic Chemistry. 2018 Apr;77:600-607.
    2018-01-01 Identification of an oxime-containing C-glucosylarene as a potential inhibitor of sodium-dependent glucose co-transporter 2 European Journal of Medicinal Chemistry. 2018 Jan 1;143:611-620.
    2017-06-22 Targeting coronaviral replication and cellular JAK2 mediated dominant NF-kappaB activation for comprehensive and ultimate inhibition of coronaviral activity Scientific Reports. 2017 Jun 22;7:Article number 4105.
    2017-01 A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide Journal of Medicinal Chemistry. 2017 Jan;60(1):228-247.
    2016-05 N-Indolylglycosides bearing modifications at the glucose C6-Position as Sodium-Dependent Glucose Co-transporter 2 inhibitors Bioorganic and Medicinal Chemistry. 2016 May;24(10):2242-2250.
    2016-01 Phenyl benzenesulfonylhydrazides exhibit selective Indoleamine 2,3-Dioxygenase inhibition with potent in vivo pharmacodynamic activity and antitumor efficacy Journal of Medicinal Chemistry. 2016 Jan;59(1):419-430.
    2015-07-31 作為極光激酶抑制劑的稠合雙環嘧啶化合物 HK1151694/2015-07-31
    2015-07-29 脯氨酸衍生物 ZL201080002506.6/2015-07-29
    2015-07-22 作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物 ZL200980144458.1/2015-07-22
    2015-07 Development and application of a fluorescent glucose uptake assay for the high-throughput screening of non-glycoside SGLT2 inhibitors European Journal of Pharmaceutical Sciences. 2015 Jul;74:40-44.
    2015-07 Pharmacological induction of human fetal globin gene in hydroxyurea-resistant primary adult erythroid cells Molecular and Cellular Biology. 2015 Jul;35(14):2541-2553.
    2015-07 Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations European Journal of Medicinal Chemistry. 2015 Jul;100:151-161.
    2015-06-01 治療C型肝炎病毒感染之醫藥組成物 I486160/2015-06-01
    2015-05-29 Proline derivatives JP5753185/2015-05-29
    2015-05 A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis Diabetes, Obesity and Metabolism. 2015 May;17(5):495-504.
    2015-04-14 Fused multicyclic compounds as protein kinase inhibitors US9006252B2/2015-04-14
    2015-02-24 Pyrazole compounds US8962845/2015-02-24
    2015-02-11 吡唑類化合物 I472514/2015-02-11
    2014-12-01 Morphine drives internal ribosome entry site-mediated hnRNP K translation in neurons through opioid receptor-dependent signaling Nucleic Acids Research. 2014 Dec 1;42(21):13012-13025.
    2014-11-19 咪唑-4-酮及咪唑-4-硫酮化合物 ZL200910006503.9/2014-11-19
    2014-10-29 作為極光激酶抑制劑的稠合雙環嘧啶化合物 ZL200980115577.4/2014-10-29
    2014-10-21 化合物於製造治療病毒感染的藥物之用途 I457121/2014-10-21
    2014-09-01 治療阿茲海默症或帕金森氏症之醫藥組成物 I450716/2014-09-01
    2014-09 Discovery, structure-activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonists Bioorganic and Medicinal Chemistry. 2014 Sep;22(17): 4694-4703.
    2014-08-15 Anticancer oral formulation 特許第5596680號/2014-08-15
    2014-08-01 Pyrrolidine derivatives 特許第5,586,484號/2014-08-01
    2014-08 Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors Bioorganic and Medicinal Chemistry Letters. 2014 Aug;24(15):3403-3406.
    2014-08 Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells Oncotarget. 2014 Aug;5(15):6087-6101.
    2014-07-30 Pyrazole compounds ZA201303800B/2014-07-30
    2014-06-04 抗癌口服制剂 ZL200980126979.4/2014-06-04
    2014-05-12 Pyrrolidine derivatives J001349/2014-05-12
    2014-05-11 二苯並〔f,h〕異喹啉衍生物及其醫藥組成物 I436983/2014-05-11
    2014-05-08 Pyrrolidine derivatives AU2009222198/2014-05-08
    2014-04-29 Quinoline compounds and their use for treating viral infection US8710079B2/2014-04-29
    2014-04-25 Pyrrolidine derivatives HK1149261/2014-04-25
    2014-04-21 咪唑-4-酮及咪唑-4-硫酮化合物 I434686/2014-04-21
    2014-04-21 作為蛋白質激酶抑制劑之吡唑化合物及噻唑化合物、其醫藥組成物及用途 I434834/2014-04-21
    2014-04-15 Glycoside compounds US8697658B2/2014-04-15
    2014-03-20 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors JP5502072/2014-03-20
    2014-03-11 脯胺酸衍生物 I429645/2014-03-11
    2014-02-19 Pyrrolidine derivatives EP2252582/2014-02-19
    2014-01-08 Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer PLoS ONE. 2014 Jan 8;9(1):Article number e83160.
    2013-12-18 吡咯烷化合物 ZL200980107941.2/2013-12-18

    Showing items 1-50 of 212. (5 Page(s) Totally)
    1 2 3 4 5 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback